Previously treated advanced endometrial cancer treated with lenvatinib plus pembrolizumab results in greater survival than chemotherapy alone
Physician's Weekly,
1. Overall survival is longer for patients receiving a combination of lenvatinib plus pembrolizumab as compared with…